HomeHealthcare and Life Sciences North America Atrophic Vaginitis Treatment Market

North America Atrophic Vaginitis Treatment Market Size, Share, Growth, and Industry Analysis, Product Type (Topical Estrogens, Vaginal Moisturizers, Laser Therapy), End User (Hospitals, Clinics, Home Care), Regional Insights and Forecast to 2034

Report Code: SMI2025PUB | Last Updated : 21 July, 2026 | Base Year : 2025 | Historical Data : 2022-2024 | Region : North America | Format : PDF, Excel | Number of Pages : 140 | Author : Jenny Burkett

Table of Contents

  1. Executive Summary
    1. Introduction
  2. Market Introduction
    1. Market Definition
    2. Scope of the Study
    3. Market Structure
  3. Research Methodology
    1. Primary Research
    2. Research Methodology
    3. Assumptions & Exclusions
    4. Secondary Data Sources
  4. Market Factor Analysis
    1. Value Chain Analysis: North America Atrophic Vaginitis Treatment Market
    2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
  6. Recent Trends Analysis
  7. Impact of COVID-19 on North America Atrophic Vaginitis Treatment Market
    1. Pre and Post Covid -19 Market Scenario Analysis
    2. Market Recovery Timeline and Challenge
    3. Measures Taken by Top Players
  8. Regulatory Landscape
  9. North America Atrophic Vaginitis Treatment Market, Product Type
    1. Introduction
      1. Market Size and Forecast, Product Type
    2. Topical Estrogens
      1. Market Size and Forecast, By Region
    3. Vaginal Moisturizers
      1. Market Size and Forecast, By Region
    4. Laser Therapy
      1. Market Size and Forecast, By Region
  10. North America Atrophic Vaginitis Treatment Market, End User
    1. Introduction
      1. Market Size and Forecast, End User
    2. Hospitals
      1. Market Size and Forecast, By Region
    3. Clinics
      1. Market Size and Forecast, By Region
    4. Home Care
      1. Market Size and Forecast, By Region
  11. Regional Overview
    1. Introduction
      1. Market Size and Forecast
    2. North America
      1. Market Size and Forecast
        1. Product Type
          1. Topical Estrogens
            1. Vaginal Moisturizers
              1. Laser Therapy
              2. End User
                1. Hospitals
                  1. Clinics
                    1. Home Care
                  2. U.S.
                    1. Product Type
                      1. Topical Estrogens
                        1. Vaginal Moisturizers
                          1. Laser Therapy
                          2. End User
                            1. Hospitals
                              1. Clinics
                                1. Home Care
                              2. Canada
                          3. Competitive Landscape, 2025
                            1. Introduction
                            2. North America Atrophic Vaginitis Treatment Market Share Analysis, 2025 (%)
                              1. Market Share Analysis, 2025
                              2. Competition Ranking, 2025
                              3. Key Developments & Growth Strategies
                                1. Merger & Acquisition
                                2. Product Launch
                                3. Expansion
                              4. Consolidated SWOT Analysis of Key Players
                          4. Company Profile
                            1. Pfizer Inc.
                              1. Business Overview
                              2. Financial Data
                              3. Key Product domains
                              4. Recent Developments
                            2. Novo Nordisk A/S
                            3. Allergan Plc
                            4. Ferring Pharmaceuticals
                            5. Hologic Inc.
                            6. Bayer AG
                            7. TherapeuticsMD
                            8. Mithra Pharmaceuticals
                            9. GlaxoSmithKline
                            10. Endoceutics
                            11. Mylan N.V.
                            12. Menlo Therapeutics
                            13. Johnson & Johnson
                            14. Organon & Co.
                            15. AbbVie Inc.